Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | +3.30% | -5.53% | +16.05% |
Jun. 10 | William Blair Starts Tenaya Therapeutics With Outperform Rating | MT |
May. 16 | Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.05% | 286M | |
+49.41% | 57.87B | |
+41.65% | 40.25B | |
-6.72% | 39.94B | |
-5.96% | 28.54B | |
+12.99% | 26.4B | |
-19.82% | 19.33B | |
+32.35% | 12.4B | |
-0.08% | 12.23B | |
+25.18% | 12.2B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Chardan Trims Price Target on Tenaya Therapeutics to $23 From $24, Maintains Buy Rating